Synopsys, Inc. - Common Stock (NQ:SNPS)

505.62 +17.15 (+3.51%)

Delayed Quote Updated: 2:10 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Synopsys, Inc. - Common Stock

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

39 40 Next >

NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday ↗

February 22, 2024

U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday.

Via Benzinga

Topics Stocks

Why Synopsys Stock Is Up After Earnings ↗

February 22, 2024

Synopsys also issued strong guidance and said it sees second-quarter adjusted earnings of between $3.09 and $3.14 per share, versus the $3.01 estimate, and second-quarter revenue between $1.56 billion...

Via Benzinga

Synopsys Inc. (NASDAQ: SNPS) Making Surprising Moves in Thursday Session

February 22, 2024

Via Investor Brand Network

Synopsys Q1 Earnings: EPS Beat, In-Line Revenue, Strong Guidance And More ↗

February 21, 2024

Synopsys reported quarterly earnings of $3.56 per share which beat the analyst consensus estimate of $3.43 by 3.79%. The company reported quarterly sales of $1.65 billion, in-line with the analyst...

Via Benzinga

Spotlight on Synopsys: Analyzing the Surge in Options Activity ↗

February 21, 2024

Via Benzinga

Earnings Scheduled For February 21, 2024 ↗

February 21, 2024

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.

Via Benzinga

Critical Insights From Synopsys Analyst Ratings: What You Need To Know ↗

February 20, 2024

Via Benzinga

Chip Design Firm Synopsys Delivers Higher Profits On In-Line Sales ↗

February 21, 2024

Chip design software firm Synopsys topped analyst estimates for earnings on in-line sales for its fiscal first quarter. SNPS stock rose.

Via Investor's Business Daily

Intel Creating Systems Foundry For AI Era, Adds Microsoft As Customer ↗

February 21, 2024

Intel detailed plans to create the first systems foundry for the AI era and added Microsoft as a customer. But Intel stock fell.

Via Investor's Business Daily

Topics Artificial Intelligence

Wall Street Falters Ahead Of Fed Minutes, Nvidia Earnings, Cybersecurity Selloff: What's Driving Markets Wednesday? ↗

February 21, 2024

Wall Street saw a muted trading session as major indices dipped into the red by midday in New York.

Via Benzinga

Topics Economy

Health Care Becomes Most Overweighted Sector As Hedge Funds Crowd Into Magnificent 7 ↗

February 21, 2024

Goldman Sachs' Hedge Fund Trend Monitor highlights concentration in mega-caps, with optimism in AI and health care.

Via Benzinga

Topics Artificial Intelligence

Should you consider NASDAQ:SNPS for quality investing? ↗

February 19, 2024

Should Quality-Oriented Investors Explore SYNOPSYS INC (NASDAQ:SNPS)?

Via Chartmill

Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

February 20, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Wall Street is surprisingly most bullish on these 3 Nasdaq stocks

February 14, 2024

Analysts are gradually shifting toward underperforming, less prominent names to find the next big thing - including these three current Wall Street faves

Via MarketBeat

Should Investors Buy Synopsys Stock in 2024? ↗

February 10, 2024

Synopsys is demonstrating robust revenue growth as it benefits from increased demand for chip design technology.

Via The Motley Fool

Here's How Much $1000 Invested In Synopsys 15 Years Ago Would Be Worth Today ↗

February 09, 2024

Via Benzinga

7 Tech Stocks Primed for a Red-Hot 2024 ↗

February 09, 2024

Tech stocks had a great 2023 and are projected to be just as strong this year. These tech stocks are leading the charge.

Via InvestorPlace

Market Whales and Their Recent Bets on SNPS Options ↗

February 06, 2024

Via Benzinga

Unpacking the Latest Options Trading Trends in Synopsys ↗

February 02, 2024

Via Benzinga

7 Stocks to Buy to Outperform ‘The Magnificent Seven’ ↗

February 07, 2024

Looking beyond the Big Tech elites? These under-the-radar companies can handily beat 'The Magnificent Seven,' if they continue to execute.

Via InvestorPlace

Nvidia Is Banking On Chatbots, AI To Speed Up Chip Design Amid Growing Demand: Report ↗

February 07, 2024

While AI-based tools have their limitations, they are proving to be invaluable for training new chip designers, writing hardware languages, and reporting bugs.

Via Benzinga

Topics Artificial Intelligence

Amazon Partner MongoDB Breaks Out, Leads Three AI Stocks Near Buy Points ↗

February 03, 2024

The database software firm broke out Friday, one of five stocks to watch.

Via Investor's Business Daily

Topics Artificial Intelligence

Looking Into Synopsys's Recent Short Interest ↗

February 01, 2024

Via Benzinga

With the Synopsys Mega-Merger on the Horizon, Does This Top Chip Design Company Stand a Chance? ↗

January 30, 2024

Keysight Technologies is facing some stiff competition, and one of its peers was recently acquired.

Via The Motley Fool

Is NASDAQ:SNPS suited for quality investing? ↗

January 29, 2024

Why SYNOPSYS INC (NASDAQ:SNPS) Deserves Consideration as a Quality Investment.

Via Chartmill

Expedia, AI Play Lead Five Stocks Near Buy Points ↗

January 27, 2024

Strong GDP data gave consumer stocks a boost.

Via Investor's Business Daily

Topics Artificial Intelligence

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Karuna Therapeutics, Inc. (Nasdaq – KRTX), Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST)

January 26, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

These 5 growth stocks are now in buy ranges

January 25, 2024

Affirm, MongoDB, UIPath, Synopsys and Crispr's charts signal buy opportunities as these top-performing tech and biotech stocks consolidate below prior highs.

Via MarketBeat

Topics ETFs

4 Stocks to Buy for the Coming AI Wars ↗

January 23, 2024

You don't want to be caught on the wrong side of the AI war. Here are four stocks to buy to protect yourself... and profit.

Via InvestorPlace

Topics Artificial Intelligence

S&P 500, Dow Extend All-Time Highs: 'It's A Lot Of Fun For Stock Investors While It Lasts,' Wall Street Veteran Says ↗

January 22, 2024

Stock market continues upward trend, with all major indexes reaching record highs. Wall Street veteran Ed Yardeni outlines three possible scenarios.

Via Benzinga

Topics Stocks

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.